Liotech Industries IPO: GMP, Price, Dates & Review

Thinking of applying to the Liotech Industries IPO? Check the latest grey market premium (GMP), ₹321 fixed price band, timeline, and lot size details. 

Here is a comprehensive breakdown of the Liotech Industries Limited IPO GMP and summarizing the vital data, financial trends, and core risks to help you make an informed decision.

1. IPO Timeline & Key Details

Liotech Industries is a fixed-price SME IPO aimed at raising ₹36.02 crores.

• Fixed Issue Price: ₹321 per share

• Lot Size (Retail Minimum): 2 Lots (800 shares total)

• Minimum Investment: ₹2,56,800

• Fresh Issue vs. OFS: ₹28.89 Cr (Fresh Issue) + ₹7.13 Cr (Offer for Sale)
  
  

2. Current Grey Market Premium (GMP)

Current GMP: ₹0 (As of June 15, 2026)

Unofficial grey market activity shows zero premium over the issue price, indicating flat sentiment and an expected listing price right at ₹321. Keep in mind that SME GMP can be highly volatile and change quickly as the subscription days unfold.

3. Financial Performance (At a Glance)

The company’s top and bottom lines have shown aggressive scaling over the last few fiscal cycles:

The Good:

• Strong Efficiencies: Return on Equity (RoE) sits at a high 34.44% (Dec 2025) and Return on Capital Employed (RoCE) is at 44.45%.

• Deleveraging: The debt-to-equity ratio has dropped steadily from 0.58 to 0.30, and nearly ₹5 Cr of the IPO proceeds will go explicitly toward wiping out remaining loans.
  
  

4. Investment Verdict: Should You Apply?

Reasons to Consider (Strengths)

1. Healthy Industry Tailwinds: They provide customized components (hinges, locks, frames) across 150 specifications to real estate, infrastructure, and solar energy fields—all of which are riding massive domestic capex trends.

2. Productive Fund Deployment: The rest of the fresh cash will expand capacity by buying machinery (₹8 Cr) and fueling active working capital (₹7 Cr).

3. End-to-End Control: Their main plant in Rajkot manages the entire cycle in-house (designing, prototyping, treating, and testing), protecting product consistency.
   
   

Reasons to Be Cautious (Risks)

1. Sudden Margin Expansion: The massive spike in net profit margins from FY23 to FY25 raises questions about whether this high level of profitability is sustainable or if it's optimized specifically for the public listing.

2. Concentration Vulnerabilities: The business relies heavily on a limited pool of customers without long-term supply contracts, and over 98% of its revenue originates exclusively from Western and Eastern India (leaving South India completely untapped).

3. Aggressive Pricing Valuation: P/E valuation at the offer price sits around 23.12x based on FY25 earnings. Given that the hardware space is highly fragmented and faces intense competition from unorganized local players, the premium looks stiff.
   
   

Final Take

Avoid or Exercise High Caution. Unless the institutional or high-net-worth individual (HNI) subscription figures skyrocket on Day 2 and Day 3 to push up demand, the current ₹0 GMP coupled with aggressive pricing suggests limited listing-day gains. Only aggressive investors with an appetite for long-term SME exposure should apply.